Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Kebede H. Begna; Nadine H. Abdallah; Michelle Janania-Martinez; Abhishek A. Mangaonkar; Aruna Rangan; Jennifer L. Herrick; Naseema Gangat

doi:10.3324/haematol.2023.283740

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Kebede H. Begna, Nadine H. Abdallah, Michelle Janania-Martinez, Abhishek A. Mangaonkar, Aruna Rangan, Jennifer L. Herrick, Naseema Gangat

Hematology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	689-692
Number of pages	4
Journal	Haematologica
Volume	109
Issue number	2
DOIs	https://doi.org/10.3324/haematol.2023.283740
State	Published - Feb 2024

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2023.283740

Cite this

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant. / Begna, Kebede H.; Abdallah, Nadine H.; Janania-Martinez, Michelle et al.
In: Haematologica, Vol. 109, No. 2, 02.2024, p. 689-692.

Research output: Contribution to journal › Article › peer-review

@article{b7449353a05f4705b01af8dde41a8c0f,

title = "Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant",

author = "Begna, {Kebede H.} and Abdallah, {Nadine H.} and Michelle Janania-Martinez and Mangaonkar, {Abhishek A.} and Aruna Rangan and Herrick, {Jennifer L.} and Naseema Gangat",

year = "2024",

month = feb,

doi = "10.3324/haematol.2023.283740",

language = "English (US)",

volume = "109",

pages = "689--692",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "2",

}

TY - JOUR

T1 - Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

AU - Begna, Kebede H.

AU - Abdallah, Nadine H.

AU - Janania-Martinez, Michelle

AU - Mangaonkar, Abhishek A.

AU - Rangan, Aruna

AU - Herrick, Jennifer L.

AU - Gangat, Naseema

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85184147937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85184147937&partnerID=8YFLogxK

U2 - 10.3324/haematol.2023.283740

DO - 10.3324/haematol.2023.283740

M3 - Article

C2 - 37706335

AN - SCOPUS:85184147937

SN - 0390-6078

VL - 109

SP - 689

EP - 692

JO - Haematologica

JF - Haematologica

IS - 2

ER -

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this